Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danhong timing around PCI in STEMI
ChiCTR1900021440Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jan 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of danhong injection in acute ST-segment elevation myocardial infarction (STEMI) (3 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: ST-segment resolution rate. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
danhong injection
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ChiCTR1900021440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021440.